IL157544A0 - Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors - Google Patents
Methods and intermediates for preparing 4-aminoquinoline cetp inhibitorsInfo
- Publication number
- IL157544A0 IL157544A0 IL15754402A IL15754402A IL157544A0 IL 157544 A0 IL157544 A0 IL 157544A0 IL 15754402 A IL15754402 A IL 15754402A IL 15754402 A IL15754402 A IL 15754402A IL 157544 A0 IL157544 A0 IL 157544A0
- Authority
- IL
- Israel
- Prior art keywords
- aminoquinoline
- intermediates
- preparing
- methods
- cetp inhibitors
- Prior art date
Links
- FQYRLEXKXQRZDH-UHFFFAOYSA-N 4-aminoquinoline Chemical compound C1=CC=C2C(N)=CC=NC2=C1 FQYRLEXKXQRZDH-UHFFFAOYSA-N 0.000 title 2
- 239000003354 cholesterol ester transfer protein inhibitor Substances 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
- C07C271/64—Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Quinoline Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28752201P | 2001-04-30 | 2001-04-30 | |
PCT/IB2002/001214 WO2002088085A2 (en) | 2001-04-30 | 2002-04-08 | Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
IL157544A0 true IL157544A0 (en) | 2004-03-28 |
Family
ID=23103272
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15754602A IL157546A0 (en) | 2001-04-30 | 2002-04-08 | Compounds useful as intermediates for 4-aminoquinoline derivatives |
IL15754402A IL157544A0 (en) | 2001-04-30 | 2002-04-08 | Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15754602A IL157546A0 (en) | 2001-04-30 | 2002-04-08 | Compounds useful as intermediates for 4-aminoquinoline derivatives |
Country Status (25)
Country | Link |
---|---|
US (3) | US6689897B2 (pt) |
EP (2) | EP1383734B1 (pt) |
JP (2) | JP3924250B2 (pt) |
KR (2) | KR100591998B1 (pt) |
CN (3) | CN1297541C (pt) |
AR (3) | AR036331A1 (pt) |
AT (2) | ATE316957T1 (pt) |
AU (1) | AU2002253448B2 (pt) |
BR (2) | BR0209291A (pt) |
CA (2) | CA2445623A1 (pt) |
CZ (2) | CZ20032898A3 (pt) |
DE (2) | DE60210265T2 (pt) |
DK (2) | DK1425270T3 (pt) |
ES (2) | ES2259080T3 (pt) |
HK (1) | HK1062294A1 (pt) |
HU (2) | HU225777B1 (pt) |
IL (2) | IL157546A0 (pt) |
MX (2) | MXPA03009936A (pt) |
PL (2) | PL366700A1 (pt) |
PT (1) | PT1425270E (pt) |
RU (2) | RU2259355C2 (pt) |
TW (1) | TWI250974B (pt) |
WO (2) | WO2002088069A2 (pt) |
YU (2) | YU84303A (pt) |
ZA (2) | ZA200306599B (pt) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197786B1 (en) * | 1998-09-17 | 2001-03-06 | Pfizer Inc | 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines |
US20040002615A1 (en) * | 2002-06-28 | 2004-01-01 | Allen David Robert | Preparation of chiral amino-nitriles |
JP2006021999A (ja) * | 2002-07-12 | 2006-01-26 | Kaneka Corp | 光学活性β−アミノニトリル化合物およびその対掌体アミド化合物の製造方法 |
US20090181966A1 (en) * | 2002-10-04 | 2009-07-16 | Millennium Pharmaceuticals, Inc. | PGD2 receptor antagonists for the treatment of inflammatory diseases |
US7504508B2 (en) | 2002-10-04 | 2009-03-17 | Millennium Pharmaceuticals, Inc. | PGD2 receptor antagonists for the treatment of inflammatory diseases |
EA011385B1 (ru) | 2002-10-04 | 2009-02-27 | Миллениум Фармасьютикалз, Инк. | Антагонисты рецептора pgd2 для лечения воспалительных заболеваний |
DE60323536D1 (de) | 2002-12-20 | 2008-10-23 | Pfizer Prod Inc | Dosierungsform enthaltend einen cetp-hemmer und einen hmg-coa reduktase hemmer |
US7601842B2 (en) | 2003-02-18 | 2009-10-13 | Takasago International Corporation | Method for producing an optically active tetrahydroquinoline |
BRPI0407954A (pt) * | 2003-03-17 | 2006-03-07 | Kaneka Corp | processo para a produção de derivado de amida de ácido (r)-3-[4-(trifluorometil) fenilamino]-pentanóico |
US7223859B2 (en) | 2003-03-17 | 2007-05-29 | Pfizer Inc. | Method for producing (R)-3-[4-(trifluoromethyl) phenylamino]-pentanoic acid amide derivative |
WO2005030185A2 (en) | 2003-09-26 | 2005-04-07 | Japan Tobacco Inc. | Method of inhibiting remnant lipoprotein production |
US7749992B2 (en) * | 2003-10-08 | 2010-07-06 | Eli Lilly And Company | Compounds and methods for treating dislipidemia |
CA2543596A1 (en) * | 2003-11-07 | 2005-05-26 | Jj Pharma, Inc. | Hdl-boosting combination therapy complexes |
WO2005100321A1 (en) * | 2004-04-07 | 2005-10-27 | Millennium Pharmaceuticals, Inc. | Pgd2 receptor antagonists for the treatment of inflammatory diseases |
EP1761521A1 (en) * | 2004-06-24 | 2007-03-14 | Eli Lilly And Company | Compounds and methods for treating dyslipidemia |
DE102004031656A1 (de) * | 2004-06-30 | 2006-01-19 | Merck Patent Gmbh | Tetrahydrochinoline |
WO2006069162A1 (en) * | 2004-12-20 | 2006-06-29 | Reddy Us Therapeutics, Inc. | Novel heterocyclic compounds and their pharmaceutical compositions |
KR20070114762A (ko) | 2005-02-24 | 2007-12-04 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | 염증 질환 치료를 위한 pgd2 수용체 길항제 |
AR058007A1 (es) * | 2005-06-20 | 2008-01-23 | Astrazeneca Ab | Proceso para la produccion de sulfonatos de (alcoxicarbonilamino) - alquilo |
UY30244A1 (es) | 2006-03-30 | 2007-11-30 | Tanabe Seiyaku Co | Un proceso para preparar derivados de tetrahidroquinolina |
DE102006031143A1 (de) * | 2006-07-04 | 2008-01-24 | Merck Patent Gmbh | Fluortenside |
DE102006031151A1 (de) * | 2006-07-04 | 2008-01-10 | Merck Patent Gmbh | Fluortenside |
DE102006032391A1 (de) * | 2006-07-04 | 2008-01-17 | Merck Patent Gmbh | Fluortenside |
DE102006031149A1 (de) * | 2006-07-04 | 2008-01-10 | Merck Patent Gmbh | Fluortenside |
DE102006031262A1 (de) * | 2006-07-04 | 2008-01-10 | Merck Patent Gmbh | Fluortenside |
WO2008112166A2 (en) | 2007-03-09 | 2008-09-18 | Indigene Pharmaceuticals Inc. | Combination of metformin r-(+) lipoate and antihyperlipidemic agents for the treatment of diabetic hyperglycemia and diabetic complications |
JP2011256110A (ja) * | 2008-09-30 | 2011-12-22 | Takeda Chem Ind Ltd | ヘキサヒドロピロロキノリンの製造法 |
AR077208A1 (es) | 2009-06-30 | 2011-08-10 | Lilly Co Eli | Derivados del acido trans-4-[[(5s)-5-[[[3,5-bis(trifluorometil) fenil] metil] (2-metil-2h-tetrazol-5-il) amino) -2,3,4,5-tetrahidro-7,9-dimetil-1h-1-benzazepin-1-il) metil)-ciclohexancarboxilico y sus formas cristalinas, composiciones farmaceuticas que los comprenden, su uso para preparar un medicam |
US9371294B2 (en) | 2011-04-12 | 2016-06-21 | Chong Kun Dang Pharmaceutical Corp. | Cycloalkenyl aryl derivatives for CETP inhibitor |
SG10201605304VA (en) | 2011-07-08 | 2016-08-30 | Novartis Ag | Method of treating atherosclerosis in high triglyceride subjects |
CN105143193B (zh) | 2013-01-31 | 2017-12-15 | 株式会社钟根堂 | 作为cetp抑制剂的联芳基或杂环联芳基取代的环己烯衍生化合物 |
KR20160072265A (ko) * | 2013-11-11 | 2016-06-22 | 론자 아게 (론자 엘티디.) | 루이스 산을 갖는 13 족의 시아노 화합물의 제조 방법 |
SI3180314T1 (sl) * | 2014-08-12 | 2022-11-30 | Newamsterdam Pharma B.V. | Postopek za pripravo sintetičnih intermediatov za pripravo derivatov tetrahidrokinolina |
CN105294559B (zh) * | 2015-06-24 | 2017-11-14 | 厦门法茉维特动物药业有限公司 | 一种医药中间体4‑氨基喹啉类化合物的合成方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69935933T2 (de) | 1998-07-10 | 2008-01-10 | Massachusetts Institute Of Technology, Cambridge | Liganden für Metalle und verbesserte Metall-katalysierte Verfahren, die darauf basieren |
GT199900147A (es) | 1998-09-17 | 1999-09-06 | 1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas. | |
US6197786B1 (en) | 1998-09-17 | 2001-03-06 | Pfizer Inc | 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines |
-
2002
- 2002-04-08 CN CNB028091442A patent/CN1297541C/zh not_active Expired - Fee Related
- 2002-04-08 AU AU2002253448A patent/AU2002253448B2/en not_active Ceased
- 2002-04-08 PT PT02722567T patent/PT1425270E/pt unknown
- 2002-04-08 KR KR1020037014135A patent/KR100591998B1/ko not_active IP Right Cessation
- 2002-04-08 IL IL15754602A patent/IL157546A0/xx unknown
- 2002-04-08 RU RU2003131870/04A patent/RU2259355C2/ru not_active IP Right Cessation
- 2002-04-08 YU YU84303A patent/YU84303A/sh unknown
- 2002-04-08 CN CNB028091663A patent/CN1267411C/zh not_active Expired - Fee Related
- 2002-04-08 ES ES02722567T patent/ES2259080T3/es not_active Expired - Lifetime
- 2002-04-08 MX MXPA03009936A patent/MXPA03009936A/es active IP Right Grant
- 2002-04-08 CZ CZ20032898A patent/CZ20032898A3/cs unknown
- 2002-04-08 KR KR1020037014134A patent/KR100639745B1/ko not_active IP Right Cessation
- 2002-04-08 WO PCT/IB2002/001217 patent/WO2002088069A2/en active IP Right Grant
- 2002-04-08 IL IL15754402A patent/IL157544A0/xx unknown
- 2002-04-08 BR BR0209291-3A patent/BR0209291A/pt not_active IP Right Cessation
- 2002-04-08 JP JP2002585373A patent/JP3924250B2/ja not_active Expired - Fee Related
- 2002-04-08 CZ CZ20032900A patent/CZ20032900A3/cs unknown
- 2002-04-08 JP JP2002585387A patent/JP3924251B2/ja not_active Expired - Fee Related
- 2002-04-08 CA CA002445623A patent/CA2445623A1/en not_active Abandoned
- 2002-04-08 PL PL02366700A patent/PL366700A1/xx not_active Application Discontinuation
- 2002-04-08 YU YU84403A patent/YU84403A/sh unknown
- 2002-04-08 EP EP02722569A patent/EP1383734B1/en not_active Expired - Lifetime
- 2002-04-08 MX MXPA03009935A patent/MXPA03009935A/es active IP Right Grant
- 2002-04-08 DE DE60210265T patent/DE60210265T2/de not_active Expired - Fee Related
- 2002-04-08 HU HU0304041A patent/HU225777B1/hu not_active IP Right Cessation
- 2002-04-08 WO PCT/IB2002/001214 patent/WO2002088085A2/en active IP Right Grant
- 2002-04-08 EP EP02722567A patent/EP1425270B1/en not_active Expired - Lifetime
- 2002-04-08 HU HU0304039A patent/HUP0304039A3/hu unknown
- 2002-04-08 AT AT02722569T patent/ATE316957T1/de not_active IP Right Cessation
- 2002-04-08 PL PL02366584A patent/PL366584A1/xx not_active Application Discontinuation
- 2002-04-08 DE DE60209004T patent/DE60209004T2/de not_active Expired - Fee Related
- 2002-04-08 DK DK02722567T patent/DK1425270T3/da active
- 2002-04-08 CA CA002445693A patent/CA2445693A1/en not_active Abandoned
- 2002-04-08 BR BR0209238-7A patent/BR0209238A/pt not_active IP Right Cessation
- 2002-04-08 DK DK02722569T patent/DK1383734T3/da active
- 2002-04-08 ES ES02722569T patent/ES2256461T3/es not_active Expired - Lifetime
- 2002-04-08 CN CNB2005100529529A patent/CN100357265C/zh not_active Expired - Fee Related
- 2002-04-08 AT AT02722567T patent/ATE321755T1/de not_active IP Right Cessation
- 2002-04-08 RU RU2003131871/04A patent/RU2265010C2/ru not_active IP Right Cessation
- 2002-04-24 TW TW091108446A patent/TWI250974B/zh not_active IP Right Cessation
- 2002-04-29 AR ARP020101576A patent/AR036331A1/es unknown
- 2002-04-29 AR ARP020101575A patent/AR035963A1/es unknown
- 2002-04-30 US US10/137,314 patent/US6689897B2/en not_active Expired - Fee Related
- 2002-04-30 US US10/136,758 patent/US6600045B2/en not_active Expired - Fee Related
-
2003
- 2003-04-18 US US10/418,821 patent/US6706881B2/en not_active Expired - Fee Related
- 2003-08-25 ZA ZA200306599A patent/ZA200306599B/en unknown
- 2003-08-25 ZA ZA200306600A patent/ZA200306600B/en unknown
-
2004
- 2004-06-15 AR ARP040102071A patent/AR044706A2/es not_active Application Discontinuation
- 2004-07-19 HK HK04105255A patent/HK1062294A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL157544A0 (en) | Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors | |
AU2002335090A8 (en) | Methods and apparatuses for identification | |
AU2003270785A1 (en) | Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof | |
IL200255A (en) | Method of preparing o-desmethyl-venlafaxine | |
HUP0302756A3 (en) | Flux and process for hot dip galvanization | |
EP1451156A4 (en) | 4-AMINOQUINOLINE COMPOUNDS | |
SI1185536T1 (en) | Hemisynthetic method and intermediates thereof | |
GB2389609B (en) | Method for use of thru-tubing stackagle perforating gun system | |
ZA200501380B (en) | Process for preparing quinolone antibiotic intermediates | |
AU2003253188A8 (en) | Novel processes and intermediates for preparing triazolo-pyridines | |
EP1372631A4 (en) | METHOD AND FORMULA FOR ANTITUMOR AND ANTIMETASTATIC EFFECT | |
GB0222909D0 (en) | Novel process and intermediates | |
GB0117557D0 (en) | Apparatus and method for workflow | |
EP1406855A4 (en) | NOVEL PROCESS FOR THE PREPARATION OF RAC-BICALUTAMIDE AND INTERMEDIATE PRODUCTS THEREOF | |
GB0104422D0 (en) | Quinoline derivative | |
GB0222912D0 (en) | Novel process and intermediates | |
GB0117539D0 (en) | Apparatus and method for workflow | |
SG96670A1 (en) | Method for supporting the orders received of transformer | |
GB0025973D0 (en) | Method of telepone caller identification | |
HUP0303846A3 (en) | Process for prodcuing quinoline carboxyaldehyde derivative and intermediate thereof | |
GB2371731B (en) | Method of alignment | |
PL376796A1 (pl) | Sposób wytwarzania inhibitorów fosfodiesterazy-4 | |
AU2003213281A8 (en) | Process and intermediates for preparing phenylthiomethyl-thiazoles or oxazoles | |
GB0029539D0 (en) | Method for identifying modulatorss of transcription | |
GB0117558D0 (en) | Apparatus and method for workflow |